학술논문
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
Document Type
Article
Author
Riudavets, M.; Tagliamento, M.; Benítez, J.-C.; Besse, B.; Planchard, D.; Auclin, E.; Mussat, E.; Mosteiro, M.; Nadal, E.; Dempsey, N.; Lopes, G.; Majem, M.; Prelaj, A.; Signorelli, D.; López-Castro, R.; Bosch-Barrera, J.; Pilotto, S.; Escalera, E.; Mosquera, J.; Garcia-Campelo, R.; Zalcman, G.; Aboubakar Nana, F.; Ponce, S.; Albarrán-Artahona, V.; Reyes, R.; Mezquita, L.; Dal Maso, A.; Menis, J.; Spotti, M.; Bluthgen, V.; Mielgo, X.; Campayo, M.; Lupinacci, L.; Duchemann, B.; De Giglio, A.; Blaquier, J.B.; Recondo, G.; Audigier-Valette, C.; Scheffler, M.
Source
In: Clinical Lung Cancer . (Clinical Lung Cancer, May 2024, 25(3):233-243.e8)
Subject
Language
English
ISSN
19380690
15257304
15257304